Canadian companies’ R&D spending grew 1.3% in 2016 to reach $12.8 billion, according to a report of Top 100 Corporate R&D Spenders by Research Infosource Inc. By comparison, R&D spending increased by 6.9% between 2014 and 2015.
Organization: Valeant Pharmaceuticals International Inc
Modest spending increases suggest Canadian companies still value R&D
R&D spending Canadian companies grew at a modest 1.3% in 2016 to reach $12.8 billion, according to a report of Top 100 Corporate R&D Spenders. The growth in FY16, however, pales in comparison to the 6.9% increase between 2014 and 2015.